anacardic acid has been researched along with paclitaxel in 2 studies
Studies (anacardic acid) | Trials (anacardic acid) | Recent Studies (post-2010) (anacardic acid) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
177 | 1 | 120 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ghadi, R; Jain, S; Katiyar, SS; Kushwah, V; Rege, MD | 1 |
Gnanaprakasam, JNR; López-Bañuelos, L; Vega, L | 1 |
2 other study(ies) available for anacardic acid and paclitaxel
Article | Year |
---|---|
Exploring an interesting dual functionality of anacardic acid for efficient paclitaxel delivery in breast cancer therapy.
Topics: Anacardic Acids; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Survival; Drug Carriers; Drug Compounding; Drug Liberation; Female; Gelatin; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Nanoparticles; Paclitaxel; Particle Size; Rats, Sprague-Dawley; Surface Properties | 2019 |
Anacardic 6-pentadecyl salicylic acid induces apoptosis in breast cancer tumor cells, immunostimulation in the host and decreases blood toxic effects of taxol in an animal model.
Topics: Anacardic Acids; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Immunity, Cellular; Immunization; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Paclitaxel | 2021 |